CKD
Live / Applied — Response to non-final action entered (as of 09 Sept 2026)
What this means for you
Not registered yet, but its 28 Jan 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79420083
- Mark type
- Stylized text
- Filed
- 28 Jan 2025
- Attorney of record
- Alexis P. Grilli
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, targeted protein degrader for the treatment, prevention and alleviation of oncologic diseases; pharmaceuticals namely targeted protein degrader for the treatment, prevention and alleviation of oncologic diseases; medicines for human purposes namely, targeted protein degrader for the treatment, prevention and alleviation of oncologic diseases; target protein degrader namely, pharmaceutical preparations for the treatment, prevention and alleviation of oncologic diseases
- Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals namely targeted protein degrader for the treatment, prevention and alleviation of oncologic diseases
- Class 042 — Scientific and technological services: Testing, inspection or research of pharmaceuticals namely targeted protein degrader for the treatment, prevention and alleviation of oncologic diseases; consulting services in the field of testing, inspection or research of pharmaceuticals namely, targeted protein degrader for the treatment, prevention and alleviation of oncologic diseases; providing scientific information about medical testing of pharmaceuticals, and providing scientific testing, inspection and research information in the field of pharmaceuticals namely, targeted protein degrader for the treatment, prevention and alleviation of oncologic diseases; Medical and scientific research, namely, conducting clinical trials for others in the field of pharmaceuticals in the field of targeted protein degrader for the treatment, prevention and alleviation of oncologic diseases; research and development services in the field of pharmaceutical preparations namely, targeted protein degrader for the treatment, prevention and alleviation of oncologic diseases
Owner
Prosecution history
- 10 Sept 2026 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 09 Sept 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Sept 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Sept 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 26 Aug 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 26 Aug 2026 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 02 Apr 2026 — REFUSAL PROCESSED BY IB
- 12 Mar 2026 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 09 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 09 Mar 2026 — NON-FINAL ACTION E-MAILED
- 09 Mar 2026 — NON-FINAL ACTION WRITTEN
- 17 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 17 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Sept 2025 — REFUSAL PROCESSED BY IB